Papers
8
Total Citations
316
H-Index
8
About
Robert Rabenalt is a leading urologic surgeon whose research has fundamentally shaped the modern approach to minimally invasive prostate cancer surgery. His work centers on comparing robotic-assisted and laparoscopic techniques, with a particular focus on radical prostatectomy outcomes. Dr. Rabenalt is best known for his pivotal role in the LAP-01 trial, the first multicentre, randomised, patient-blinded controlled study to compare robotic-assisted versus laparoscopic radical prostatectomy. This landmark work, published in 2021 with 107 citations, provided crucial evidence on surgical outcomes, oncological safety, and quality of life differences between the two approaches. His subsequent publications from the LAP-01 trial, including 12-month outcomes (51 citations) and quality of life analyses (19 citations), have further solidified his reputation. Beyond prostate surgery, Dr. Rabenalt has contributed significantly to the field of robotic cystectomy, notably comparing perioperative complications and oncological safety of robot-assisted versus open radical cystectomy (41 citations). His research on age-stratified outcomes after radical prostatectomy has provided valuable insights into how younger patients may experience different recovery trajectories. Through his rigorous clinical trials and comparative effectiveness research, Dr. Rabenalt has helped establish evidence-based standards for minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8